{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T16:22:39Z","timestamp":1776961359264,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Joint Funds of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant no.U19A2002, no.82222030 and no.82201212"],"award-info":[{"award-number":["Grant no.U19A2002, no.82222030 and no.82201212"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mucopolysaccharidosis type I (MPS I) is a severe disease caused by loss-of-function mutation variants in the \u03b1-L-iduronidase (\n                    <jats:italic>Idua<\/jats:italic>\n                    ) gene. In vivo genome editing represents a promising strategy to correct\n                    <jats:italic>Idua<\/jats:italic>\n                    mutations, and has the potential to permanently restore IDUA function over the lifespan of patients. Here, we used adenine base editing to directly convert A\u2009&gt;\u2009G (TAG&gt;TGG) in a newborn murine model harboring the\n                    <jats:italic>Idua-W392X<\/jats:italic>\n                    mutation, which recapitulates the human condition and is analogous to the highly prevalent human W402X mutation. We engineered a split-intein dual-adeno-associated virus 9 (AAV9) adenine base editor to circumvent the package size limit of AAV vectors. Intravenous injection of the AAV9-base editor system into MPS IH newborn mice led to sustained enzyme expression sufficient for correction of metabolic disease (GAGs substrate accumulation) and prevention of neurobehavioral deficits. We observed a reversion of the W392X mutation in 22.46\u2009\u00b1\u20096.74% of hepatocytes, 11.18\u2009\u00b1\u20095.25% of heart and 0.34\u2009\u00b1\u20090.12% of brain, along with decreased GAGs storage in peripheral organs (liver, spleen, lung and kidney). Collectively, these data showed the promise of a base editing approach to precisely correct a common genetic cause of MPS I in vivo and could be broadly applicable to the treatment of a wide array of monogenic diseases.\n                  <\/jats:p>","DOI":"10.1186\/s43556-023-00120-8","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T21:02:42Z","timestamp":1677099762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["In vivo adenine base editing corrects newborn murine model of Hurler syndrome"],"prefix":"10.1186","volume":"4","author":[{"given":"Jing","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiqin","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianlu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"120_CR1","doi-asserted-by":"publisher","first-page":"471325","DOI":"10.1155\/2012\/471325","volume":"2012","author":"MF Coutinho","year":"2012","unstructured":"Coutinho MF, Lacerda L, Alves S. Glycosaminoglycan storage disorders: a review. Biochem Res Int. 2012;2012:471325. https:\/\/doi.org\/10.1155\/2012\/471325.","journal-title":"Biochem Res Int"},{"key":"120_CR2","doi-asserted-by":"publisher","unstructured":"Hampe CS, Eisengart JB, Lund TC, Orchard PJ, Swietlicka M, Wesley J, et al. Mucopolysaccharidosis Type I: a review of the natural history and molecular pathology. Cells. 2020;9(8). https:\/\/doi.org\/10.3390\/cells9081838.","DOI":"10.3390\/cells9081838"},{"key":"120_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1750-1172-3-24","volume":"3","author":"D Moore","year":"2008","unstructured":"Moore D, Connock MJ, Wraith E, Lavery C. The prevalence of and survival in Mucopolysaccharidosis I: hurler, hurler-Scheie and Scheie syndromes in the UK. Orphanet J Rare Dis. 2008;3:24. https:\/\/doi.org\/10.1186\/1750-1172-3-24.","journal-title":"Orphanet J Rare Dis"},{"key":"120_CR4","doi-asserted-by":"publisher","unstructured":"Tebani A, Zanoutene-Cheriet L, Adjtoutah Z, Abily-Donval L, Brasse-Lagnel C, Laquerriere A, et al. Clinical and molecular characterization of patients with Mucopolysaccharidosis Type I in an Algerian series. Int J Mol Sci. 2016;17(5). https:\/\/doi.org\/10.3390\/ijms17050743.","DOI":"10.3390\/ijms17050743"},{"issue":"4","key":"120_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.17796\/jcpd.24.4.ku653u75nv5vt735","volume":"24","author":"S Thomas","year":"2008","unstructured":"Thomas S, Tandon S. Hurler syndrome: a case report. J Clin Pediatr Dent. 2008;24(4):335\u20138. https:\/\/doi.org\/10.17796\/jcpd.24.4.ku653u75nv5vt735.","journal-title":"J Clin Pediatr Dent"},{"issue":"2","key":"120_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/humu.1380010204","volume":"1","author":"HS Scott","year":"1992","unstructured":"Scott HS, Litjens T, Hopwood JJ, Morris CP. A common mutation for mucopolysaccharidosis type I associated with a severe hurler syndrome phenotype. Hum Mutat. 1992;1(2):103\u20138. https:\/\/doi.org\/10.1002\/humu.1380010204.","journal-title":"Hum Mutat"},{"key":"120_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ymgmr.2014.10.001","volume":"1","author":"T Pineda","year":"2014","unstructured":"Pineda T, Marie S, Gonzalez J, Garcia AL, Acosta A, Morales M, et al. Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru. Mol Genet Metab Rep. 2014;1:468\u201373. https:\/\/doi.org\/10.1016\/j.ymgmr.2014.10.001.","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"120_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/cge.13224","volume":"94","author":"E Poletto","year":"2018","unstructured":"Poletto E, Pasqualim G, Giugliani R, Matte U, Baldo G. Worldwide distribution of common IDUA pathogenic variants. Clin Genet. 2018;94(1):95\u2013102. https:\/\/doi.org\/10.1111\/cge.13224.","journal-title":"Clin Genet"},{"key":"120_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jpeds.2016.11.036","volume":"182","author":"LA Clarke","year":"2017","unstructured":"Clarke LA, Atherton AM, Burton BK, Day-Salvatore DL, Kaplan P, Leslie ND, et al. Mucopolysaccharidosis Type I newborn screening: best practices for diagnosis and management. J Pediatr. 2017;182:363\u201370. https:\/\/doi.org\/10.1016\/j.jpeds.2016.11.036.","journal-title":"J Pediatr"},{"issue":"6","key":"120_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/sj.bmt.1705934","volume":"41","author":"J Tolar","year":"2008","unstructured":"Tolar J, Grewal SS, Bjoraker KJ, Whitley CB, Shapiro EG, Charnas L, et al. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for hurler syndrome. Bone Marrow Transplant. 2008;41(6):531\u20135. https:\/\/doi.org\/10.1038\/sj.bmt.1705934.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"120_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13023-017-0662-9","volume":"12","author":"R Parini","year":"2017","unstructured":"Parini R, Deodato F, Di Rocco M, Lanino E, Locatelli F, Messina C, et al. Open issues in Mucopolysaccharidosis type I-Hurler. Orphanet J Rare Dis. 2017;12(1):112. https:\/\/doi.org\/10.1186\/s13023-017-0662-9.","journal-title":"Orphanet J Rare Dis"},{"issue":"41","key":"120_CR12","doi-asserted-by":"publisher","first-page":"14894","DOI":"10.1073\/pnas.1413645111","volume":"111","author":"C Hinderer","year":"2014","unstructured":"Hinderer C, Bell P, Gurda BL, Wang Q, Louboutin J-P, Zhu Y, et al. Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I. Proc Natl Acad Sci U S A. 2014;111(41):14894\u20139. https:\/\/doi.org\/10.1073\/pnas.1413645111.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"120_CR13","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/mt.2015.99","volume":"23","author":"C Hinderer","year":"2015","unstructured":"Hinderer C, Bell P, Louboutin JP, Zhu Y, Yu H, Lin G, et al. Neonatal systemic AAV induces tolerance to CNS gene therapy in MPS I dogs and nonhuman Primates. Mol Ther. 2015;23(8):1298\u2013307. https:\/\/doi.org\/10.1038\/mt.2015.99.","journal-title":"Mol Ther"},{"issue":"12","key":"120_CR14","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1038\/mt.2014.135","volume":"22","author":"C Hinderer","year":"2014","unstructured":"Hinderer C, Bell P, Gurda BL, Wang Q, Louboutin JP, Zhu Y, et al. Intrathecal gene therapy corrects CNS pathology in a feline model of mucopolysaccharidosis I. Mol Ther. 2014;22(12):2018\u201327. https:\/\/doi.org\/10.1038\/mt.2014.135.","journal-title":"Mol Ther"},{"issue":"6","key":"120_CR15","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.ymthe.2020.03.018","volume":"28","author":"L Ou","year":"2020","unstructured":"Ou L, Przybilla MJ, Ahlat O, Kim S, Overn P, Jarnes J, et al. A highly efficacious PS gene editing system corrects metabolic and neurological complications of Mucopolysaccharidosis Type I. Mol Ther. 2020;28(6):1442\u201354. https:\/\/doi.org\/10.1016\/j.ymthe.2020.03.018.","journal-title":"Mol Ther"},{"issue":"1","key":"120_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ymthe.2018.10.018","volume":"27","author":"L Ou","year":"2019","unstructured":"Ou L, DeKelver RC, Rohde M, Tom S, Radeke R, St Martin SJ, et al. ZFN-mediated in vivo genome editing corrects murine hurler syndrome. Mol Ther. 2019;27(1):178\u201387. https:\/\/doi.org\/10.1016\/j.ymthe.2018.10.018.","journal-title":"Mol Ther"},{"key":"120_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2018.08.031","volume":"288","author":"RS Schuh","year":"2018","unstructured":"Schuh RS, Poletto \u00c9, Pasqualim G, Tavares AMV, Meyer FS, Gonzalez EA, et al. In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR\/Cas9 system. J Control Release. 2018;288:23\u201333. https:\/\/doi.org\/10.1016\/j.jconrel.2018.08.031.","journal-title":"J Control Release"},{"issue":"1","key":"120_CR18","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1038\/s41467-019-11962-8","volume":"10","author":"N Gomez-Ospina","year":"2019","unstructured":"Gomez-Ospina N, Scharenberg SG, Mostrel N, Bak RO, Mantri S, Quadros RM, et al. Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I. Nat Commun. 2019;10(1):4045. https:\/\/doi.org\/10.1038\/s41467-019-11962-8.","journal-title":"Nat Commun"},{"issue":"12","key":"120_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees HA, Liu DR. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet. 2018;19(12):770\u201388. https:\/\/doi.org\/10.1038\/s41576-018-0059-1.","journal-title":"Nat Rev Genet"},{"issue":"12","key":"120_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","volume":"19","author":"EM Porto","year":"2020","unstructured":"Porto EM, Komor AC, Slaymaker IM, Yeo GW. Base editing: advances and therapeutic opportunities. Nat Rev Drug Discov. 2020;19(12):839\u201359. https:\/\/doi.org\/10.1038\/s41573-020-0084-6.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"120_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ymgme.2009.08.002","volume":"99","author":"D Wang","year":"2010","unstructured":"Wang D, Shukla C, Liu X, Schoeb TR, Clarke LA, Bedwell DM, et al. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation. Mol Genet Metab. 2010;99(1):62\u201371. https:\/\/doi.org\/10.1016\/j.ymgme.2009.08.002.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"120_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41587-019-0134-y","volume":"37","author":"TP Huang","year":"2019","unstructured":"Huang TP, Zhao KT, Miller SM, Gaudelli NM, Oakes BL, Fellmann C, et al. Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors. Nat Biotechnol. 2019;37(6):626\u201331. https:\/\/doi.org\/10.1038\/s41587-019-0134-y.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"120_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter MF, Zhao KT, Eton E, Lapinaite A, Newby GA, Thuronyi BW, et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat Biotechnol. 2020;38(7):883\u201391. https:\/\/doi.org\/10.1038\/s41587-020-0453-z.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"120_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/crispr.2021.0109","volume":"5","author":"S-Y Yu","year":"2022","unstructured":"Yu S-Y, Birkenshaw A, Thomson T, Carlaw T, Zhang L-H, Ross CJD. Increasing the targeting scope of CRISPR Base editing system beyond NGG. CRISPR J. 2022;5(2):187\u2013202. https:\/\/doi.org\/10.1089\/crispr.2021.0109.","journal-title":"CRISPR J"},{"issue":"6","key":"120_CR25","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"C Zincarelli","year":"2008","unstructured":"Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 2008;16(6):1073\u201380. https:\/\/doi.org\/10.1038\/mt.2008.76.","journal-title":"Mol Ther"},{"issue":"1","key":"120_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","volume":"14","author":"K Inagaki","year":"2006","unstructured":"Inagaki K, Fuess S, Storm TA, Gibson GA, McTiernan CF, Kay MA, et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther. 2006;14(1):45\u201353. https:\/\/doi.org\/10.1016\/j.ymthe.2006.03.014.","journal-title":"Mol Ther"},{"issue":"1","key":"120_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13023-017-0583-7","volume":"12","author":"BT Kiely","year":"2017","unstructured":"Kiely BT, Kohler JL, Coletti HY, Poe MD, Escolar ML. Early disease progression of hurler syndrome. Orphanet J Rare Dis. 2017;12(1):32. https:\/\/doi.org\/10.1186\/s13023-017-0583-7.","journal-title":"Orphanet J Rare Dis"},{"key":"120_CR28","volume-title":"GeneReviews(\u00ae). University of Washington, Seattle Copyright \u00a9 1993-2022, University of Washington","author":"LA Clarke","year":"1993","unstructured":"Clarke LA. Mucopolysaccharidosis Type I. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews(\u00ae). University of Washington, Seattle Copyright \u00a9 1993-2022, University of Washington. Seattle: GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved; 1993."},{"issue":"6","key":"120_CR29","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","volume":"34","author":"EA Braunlin","year":"2011","unstructured":"Braunlin EA, Harmatz PR, Scarpa M, Furlanetto B, Kampmann C, Loehr JP, et al. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis. 2011;34(6):1183\u201397. https:\/\/doi.org\/10.1007\/s10545-011-9359-8.","journal-title":"J Inherit Metab Dis"},{"key":"120_CR30","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ymgmr.2014.09.003","volume":"1","author":"EM Ribeiro","year":"2014","unstructured":"Ribeiro EM, Brusius-Facchin AC, Leistner-Segal S, da Silva CAB, Schwartz IV. Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: a case report. Mol Genet Metab Rep. 2014;1:422\u20134. https:\/\/doi.org\/10.1016\/j.ymgmr.2014.09.003.","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"120_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ymgme.2022.01.104","volume":"135","author":"E Braunlin","year":"2022","unstructured":"Braunlin E, Abrahante JE, McElmurry R, Evans M, Smith M, Seelig D, et al. Contribution of the innate and adaptive immune systems to aortic dilation in murine mucopolysaccharidosis type I. Mol Genet Metab. 2022;135(3):193\u2013205. https:\/\/doi.org\/10.1016\/j.ymgme.2022.01.104.","journal-title":"Mol Genet Metab"},{"key":"120_CR32","doi-asserted-by":"publisher","unstructured":"De Ponti G, Donsante S, Frigeni M, Pievani A, Corsi A, Bernardo ME, et al. MPSI manifestations and treatment outcome: skeletal focus. Int J Mol Sci. 2022;23(19). https:\/\/doi.org\/10.3390\/ijms231911168.","DOI":"10.3390\/ijms231911168"},{"key":"120_CR33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.omtm.2022.04.010","volume":"25","author":"X Jin","year":"2022","unstructured":"Jin X, Su J, Zhao Q, Li R, Xiao J, Zhong X, et al. Liver-directed gene therapy corrects neurologic disease in a murine model of mucopolysaccharidosis type I-hurler. Mol Ther Methods Clin Dev. 2022;25:370\u201381. https:\/\/doi.org\/10.1016\/j.omtm.2022.04.010.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"120_CR34","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1073\/pnas.252784899","volume":"100","author":"K Ohmi","year":"2003","unstructured":"Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci U S A. 2003;100(4):1902\u20137. https:\/\/doi.org\/10.1073\/pnas.252784899.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"120_CR35","doi-asserted-by":"publisher","unstructured":"Feng X, Krukowski K, Jopson T, Rosi S. Delayed-matching-to-place task in a dry maze to measure spatial working memory in mice. Bio Protoc. 2017;7(13). https:\/\/doi.org\/10.21769\/BioProtoc.2389.","DOI":"10.21769\/BioProtoc.2389"},{"key":"120_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13041-016-0191-9","volume":"9","author":"H Shoji","year":"2016","unstructured":"Shoji H, Takao K, Hattori S, Miyakawa T. Age-related changes in behavior in C57BL\/6J mice from young adulthood to middle age. Mol Brain. 2016;9:11. https:\/\/doi.org\/10.1186\/s13041-016-0191-9.","journal-title":"Mol Brain"},{"issue":"3","key":"120_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/ANA.0b013e3181d56c98","volume":"22","author":"G Barreto","year":"2010","unstructured":"Barreto G, Huang TT, Giffard RG. Age-related defects in sensorimotor activity, spatial learning, and memory in C57BL\/6 mice. J Neurosurg Anesthesiol. 2010;22(3):214\u20139. https:\/\/doi.org\/10.1097\/ANA.0b013e3181d56c98.","journal-title":"J Neurosurg Anesthesiol"},{"key":"120_CR38","doi-asserted-by":"publisher","unstructured":"Posey JE. Genome sequencing and implications for rare disorders. Orphanet J Rare Dis. 2019;14(1). https:\/\/doi.org\/10.1186\/s13023-019-1127-0.","DOI":"10.1186\/s13023-019-1127-0"},{"issue":"3","key":"120_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/diagnostics10030161","volume":"10","author":"F Kubaski","year":"2020","unstructured":"Kubaski F, de Oliveira PF, Michelin-Tirelli K, Matte US, Horovitz DD, Barth AL, et al. Mucopolysaccharidosis Type I. Diagnostics. 2020;10(3):161.","journal-title":"Diagnostics"},{"issue":"s447","key":"120_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1651-2227.2005.tb02114.x","volume":"94","author":"E Miebach","year":"2005","unstructured":"Miebach E. Enzyme replacement therapy in mucopolysaccharidosis type I. Acta Paediatr. 2005;94(s447):58\u201360. https:\/\/doi.org\/10.1111\/j.1651-2227.2005.tb02114.x.","journal-title":"Acta Paediatr"},{"issue":"2","key":"120_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1023\/a:1010379320378","volume":"24","author":"JE Wraith","year":"2001","unstructured":"Wraith JE. Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties. J Inherit Metab Dis. 2001;24(2):245\u201350. https:\/\/doi.org\/10.1023\/a:1010379320378.","journal-title":"J Inherit Metab Dis"},{"key":"120_CR42","doi-asserted-by":"publisher","unstructured":"Hampe CS, Wesley J, Lund TC, Orchard PJ, Polgreen LE, Eisengart JB, et al. Mucopolysaccharidosis Type I: current treatments, limitations, and prospects for improvement. Biomolecules. 2021;11(2). https:\/\/doi.org\/10.3390\/biom11020189.","DOI":"10.3390\/biom11020189"},{"issue":"5","key":"120_CR43","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ymthe.2006.01.006","volume":"13","author":"MS Sands","year":"2006","unstructured":"Sands MS, Davidson BL. Gene therapy for lysosomal storage diseases. Mol Ther. 2006;13(5):839\u201349. https:\/\/doi.org\/10.1016\/j.ymthe.2006.01.006.","journal-title":"Mol Ther"},{"key":"120_CR44","doi-asserted-by":"publisher","unstructured":"Poletto E, Baldo G, Gomez-Ospina N. Genome editing for Mucopolysaccharidoses. Int J Mol Sci. 2020;21(2). https:\/\/doi.org\/10.3390\/ijms21020500.","DOI":"10.3390\/ijms21020500"},{"issue":"3","key":"120_CR45","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","volume":"28","author":"HC Verdera","year":"2020","unstructured":"Verdera HC, Kuranda K, Mingozzi F. AAV vector immunogenicity in humans: a long journey to successful gene transfer. Mol Ther. 2020;28(3):723\u201346. https:\/\/doi.org\/10.1016\/j.ymthe.2019.12.010.","journal-title":"Mol Ther"},{"issue":"5","key":"120_CR46","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.ymthe.2004.10.006","volume":"11","author":"H Kobayashi","year":"2005","unstructured":"Kobayashi H, Carbonaro D, Pepper K, Petersen D, Ge S, Jackson H, et al. Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. Mol Ther. 2005;11(5):776\u201389. https:\/\/doi.org\/10.1016\/j.ymthe.2004.10.006.","journal-title":"Mol Ther"},{"issue":"5","key":"120_CR47","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1073\/pnas.96.5.2296","volume":"96","author":"TM Daly","year":"1999","unstructured":"Daly TM, Vogler C, Levy B, Haskins ME, Sands MS. Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc Natl Acad Sci U S A. 1999;96(5):2296\u2013300. https:\/\/doi.org\/10.1073\/pnas.96.5.2296.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"120_CR48","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0165-3806(87)90107-6","volume":"32","author":"P Stewart","year":"1987","unstructured":"Stewart P, Hayakawa E. Interendothelial junctional changes underlie the developmental \u2018tightening\u2019of the blood-brain barrier. Brain Res. 1987;32(2):271\u201381.","journal-title":"Brain Res"},{"issue":"4","key":"120_CR49","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.ymthe.2018.03.002","volume":"26","author":"K Laoharawee","year":"2018","unstructured":"Laoharawee K, DeKelver RC, Podetz-Pedersen KM, Rohde M, Sproul S, Nguyen HO, et al. Dose-dependent prevention of metabolic and neurologic disease in murine MPS II by ZFN-mediated in vivo genome editing. Mol Ther. 2018;26(4):1127\u201336. https:\/\/doi.org\/10.1016\/j.ymthe.2018.03.002.","journal-title":"Mol Ther"},{"issue":"10","key":"120_CR50","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-018-0209-1","volume":"24","author":"L Villiger","year":"2018","unstructured":"Villiger L, Grisch-Chan HM, Lindsay H, Ringnalda F, Pogliano CB, Allegri G, et al. Treatment of a metabolic liver disease by in vivo genome base editing in adult mice. Nat Med. 2018;24(10):1519\u201325. https:\/\/doi.org\/10.1038\/s41591-018-0209-1.","journal-title":"Nat Med"},{"issue":"2","key":"120_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41551-020-00632-6","volume":"5","author":"S Suh","year":"2021","unstructured":"Suh S, Choi EH, Leinonen H, Foik AT, Newby GA, Yeh W-H, et al. Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing. Nat Biomed Eng. 2021;5(2):169\u201378. https:\/\/doi.org\/10.1038\/s41551-020-00632-6.","journal-title":"Nat Biomed Eng"},{"issue":"7843","key":"120_CR52","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","volume":"589","author":"LW Koblan","year":"2021","unstructured":"Koblan LW, Erdos MR, Wilson C, Cabral WA, Levy JM, Xiong Z-M, et al. In vivo base editing rescues Hutchinson\u2013Gilford progeria syndrome in mice. Nature. 2021;589(7843):608\u201314. https:\/\/doi.org\/10.1038\/s41586-020-03086-7.","journal-title":"Nature."},{"issue":"1","key":"120_CR53","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1038\/s41467-021-24443-8","volume":"12","author":"SK Bose","year":"2021","unstructured":"Bose SK, White BM, Kashyap MV, Dave A, De Bie FR, Li H, et al. In utero adenine base editing corrects multi-organ pathology in a lethal lysosomal storage disease. Nat Commun. 2021;12(1):4291. https:\/\/doi.org\/10.1038\/s41467-021-24443-8.","journal-title":"Nat Commun"},{"issue":"1","key":"120_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/dmcn.13600","volume":"60","author":"M Beck","year":"2018","unstructured":"Beck M. Treatment strategies for lysosomal storage disorders. Dev Med Child Neurol. 2018;60(1):13\u20138. https:\/\/doi.org\/10.1111\/dmcn.13600.","journal-title":"Dev Med Child Neurol"},{"key":"120_CR55","doi-asserted-by":"publisher","unstructured":"Huang TP, Heins ZJ, Miller SM, Wong BG, Balivada PA, Wang T, et al. High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMs. Nat Biotechnol. 2022. https:\/\/doi.org\/10.1038\/s41587-022-01410-2.","DOI":"10.1038\/s41587-022-01410-2"},{"issue":"7699","key":"120_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature26155","volume":"556","author":"JH Hu","year":"2018","unstructured":"Hu JH, Miller SM, Geurts MH, Tang W, Chen L, Sun N, et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature. 2018;556(7699):57\u201363. https:\/\/doi.org\/10.1038\/nature26155.","journal-title":"Nature."},{"issue":"1","key":"120_CR57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41587-020-0592-2","volume":"39","author":"D Zhao","year":"2021","unstructured":"Zhao D, Li J, Li S, Xin X, Hu M, Price MA, et al. Glycosylase base editors enable C-to-A and C-to-G base changes. Nat Biotechnol. 2021;39(1):35\u201340. https:\/\/doi.org\/10.1038\/s41587-020-0592-2.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"120_CR58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41587-020-0609-x","volume":"39","author":"IC Kurt","year":"2021","unstructured":"Kurt IC, Zhou R, Iyer S, Garcia SP, Miller BR, Langner LM, et al. CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells. Nat Biotechnol. 2021;39(1):41\u20136. https:\/\/doi.org\/10.1038\/s41587-020-0609-x.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"120_CR59","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41467-021-21559-9","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Park JE, Paa P, Rajakumar PD, Prekop H-T, Chew YT, et al. Programmable C:G to G:C genome editing with CRISPR-Cas9-directed base excision repair proteins. Nat Commun. 2021;12(1):1384. https:\/\/doi.org\/10.1038\/s41467-021-21559-9.","journal-title":"Nat Commun"},{"issue":"10","key":"120_CR60","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1089\/hum.2010.055","volume":"21","author":"M Lock","year":"2010","unstructured":"Lock M, Alvira M, Vandenberghe LH, Samanta A, Toelen J, Debyser Z, et al. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum Gene Ther. 2010;21(10):1259\u201371. https:\/\/doi.org\/10.1089\/hum.2010.055.","journal-title":"Hum Gene Ther"},{"issue":"2","key":"120_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1089\/hgtb.2013.131","volume":"25","author":"M Lock","year":"2014","unstructured":"Lock M, Alvira MR, Chen SJ, Wilson JM. Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR. Hum Gene Ther Methods. 2014;25(2):115\u201325. https:\/\/doi.org\/10.1089\/hgtb.2013.131.","journal-title":"Hum Gene Ther Methods"},{"issue":"3","key":"120_CR62","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nbt.3469","volume":"34","author":"Y Yang","year":"2016","unstructured":"Yang Y, Wang L, Bell P, McMenamin D, He Z, White J, et al. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat Biotechnol. 2016;34(3):334\u20138. https:\/\/doi.org\/10.1038\/nbt.3469.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"120_CR63","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/brb3.41","volume":"2","author":"M Faizi","year":"2012","unstructured":"Faizi M, Bader PL, Saw N, Nguyen TV, Beraki S, Wyss-Coray T, et al. Thy1-hAPP(Lond\/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function. Brain Behav. 2012;2(2):142\u201354. https:\/\/doi.org\/10.1002\/brb3.41.","journal-title":"Brain Behav"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-023-00120-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-023-00120-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-023-00120-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T21:07:36Z","timestamp":1677100056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-023-00120-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["120"],"URL":"https:\/\/doi.org\/10.1186\/s43556-023-00120-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.16.464213","asserted-by":"object"}]},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"12 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal protocols were performed in accordance with the guidelines of Institutional Animal Care and Concern Committee, and were approved by the Ethics Committee of West China Hospital of Sichuan University (2020095A).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}